These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25994490)

  • 1. The role of PPAR activation during the systemic response to brain injury.
    Losey P; Ladds E; Laprais M; Guevel B; Burns L; Bordet R; Anthony DC
    J Neuroinflammation; 2015 May; 12():99. PubMed ID: 25994490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of PPAR-β/δ agonist GW0742 treatment in the acute phase response and blood-brain barrier permeability following brain injury.
    Chehaibi K; le Maire L; Bradoni S; Escola JC; Blanco-Vaca F; Slimane MN
    Transl Res; 2017 Apr; 182():27-48. PubMed ID: 27818230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment.
    Deplanque D; Gelé P; Pétrault O; Six I; Furman C; Bouly M; Nion S; Dupuis B; Leys D; Fruchart JC; Cecchelli R; Staels B; Duriez P; Bordet R
    J Neurosci; 2003 Jul; 23(15):6264-71. PubMed ID: 12867511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of myeloperoxidase oxidant production by N-acetyl lysyltyrosylcysteine amide reduces brain damage in a murine model of stroke.
    Yu G; Liang Y; Huang Z; Jones DW; Pritchard KA; Zhang H
    J Neuroinflammation; 2016 May; 13(1):119. PubMed ID: 27220420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic expression of serum amyloid A1 is induced by traumatic brain injury and modulated by telmisartan.
    Villapol S; Kryndushkin D; Balarezo MG; Campbell AM; Saavedra JM; Shewmaker FP; Symes AJ
    Am J Pathol; 2015 Oct; 185(10):2641-52. PubMed ID: 26435412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective Effects of Chronic Fenofibrate Treatment via Modulating the Immunoreactivity of Cleaved Caspase-3 in Stroke Induced by Transient Middle Cerebral Artery Occlusion Rat Model.
    Altintas O; Altintas MO; Aydin MS; Baran O; Antar V; Esrefoglu M; Asil T
    Turk Neurosurg; 2017; 27(4):522-529. PubMed ID: 27509457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Withdrawal of fenofibrate treatment partially abrogates preventive neuroprotection in stroke via loss of vascular protection.
    Ouk T; Laprais M; Bastide M; Mostafa K; Gautier S; Bordet R
    Vascul Pharmacol; 2009; 51(5-6):323-30. PubMed ID: 19732852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-stroke DHA Treatment Protects Against Acute Ischemic Brain Injury by Skewing Macrophage Polarity Toward the M2 Phenotype.
    Cai W; Liu S; Hu M; Sun X; Qiu W; Zheng S; Hu X; Lu Z
    Transl Stroke Res; 2018 Dec; 9(6):669-680. PubMed ID: 30203370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
    Luo Y; Yin W; Signore AP; Zhang F; Hong Z; Wang S; Graham SH; Chen J
    J Neurochem; 2006 Apr; 97(2):435-48. PubMed ID: 16539667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myosin1f-mediated neutrophil migration contributes to acute neuroinflammation and brain injury after stroke in mice.
    Wang Y; Jin H; Wang W; Wang F; Zhao H
    J Neuroinflammation; 2019 Apr; 16(1):77. PubMed ID: 30971272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of ischemic brain injury by administration of palmitoylethanolamide after transient middle cerebral artery occlusion in rats.
    Ahmad A; Genovese T; Impellizzeri D; Crupi R; Velardi E; Marino A; Esposito E; Cuzzocrea S
    Brain Res; 2012 Oct; 1477():45-58. PubMed ID: 23046519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of treatment with low-dose gliclazide in a model of middle cerebral artery occlusion and reperfusion in rats.
    Tan F; Li H; Ma M; Yu Y
    Brain Res; 2014 Apr; 1560():83-90. PubMed ID: 24602692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-existing interleukin 10 in cerebral arteries attenuates subsequent brain injury caused by ischemia/reperfusion.
    Liang QJ; Jiang M; Wang XH; Le LL; Xiang M; Sun N; Meng D; Chen SF
    IUBMB Life; 2015 Sep; 67(9):710-9. PubMed ID: 26337686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the PPAR-α agonist fenofibrate on acute and short-term consequences of brain ischemia.
    Ouk T; Gautier S; Pétrault M; Montaigne D; Maréchal X; Masse I; Devedjian JC; Deplanque D; Bastide M; Nevière R; Duriez P; Staels B; Pasquier F; Leys D; Bordet R
    J Cereb Blood Flow Metab; 2014 Mar; 34(3):542-51. PubMed ID: 24398933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effect of lercanidipine in middle cerebral artery occlusion model of stroke in rats.
    Gupta S; Sharma U; Jagannathan NR; Gupta YK
    Exp Neurol; 2017 Feb; 288():25-37. PubMed ID: 27794423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effect of naringenin is mediated through suppression of NF-κB signaling pathway in experimental stroke.
    Raza SS; Khan MM; Ahmad A; Ashafaq M; Islam F; Wagner AP; Safhi MM; Islam F
    Neuroscience; 2013 Jan; 230():157-71. PubMed ID: 23103795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptorsgamma (PPARgamma) differently modulate the interleukin-6 expression in the peri-infarct cortical tissue in the acute and delayed phases of cerebral ischaemia.
    Patzer A; Zhao Y; Stöck I; Gohlke P; Herdegen T; Culman J
    Eur J Neurosci; 2008 Nov; 28(9):1786-94. PubMed ID: 18973594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperforin protects against acute cerebral ischemic injury through inhibition of interleukin-17A-mediated microglial activation.
    Ma L; Pan X; Zhou F; Liu K; Wang L
    Brain Res; 2018 Jan; 1678():254-261. PubMed ID: 28870826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, exerts neuroprotective effects in traumatic brain injury.
    Besson VC; Chen XR; Plotkine M; Marchand-Verrecchia C
    Neurosci Lett; 2005 Nov; 388(1):7-12. PubMed ID: 16087294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger RNA and protein express for angiogenic factors.
    Dong W; Li N; Gao D; Zhen H; Zhang X; Li F
    J Vasc Surg; 2008 Sep; 48(3):709-14. PubMed ID: 18572362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.